Company Name:Heska Corp.
CEO: Kevin S. Wilson

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.


Key numbers

Market Capitalization:897116198
Shares Outstanding: 9391920
Float: 8740158
Next Earning Date:2020-08-04
TTm EPS: -1.0022
TTm Dividend Rate:
200 days moving average:86.29
50 days moving average: 90.6
One day percent Change: -1.15



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,